TY - THES
T1 - Enteral recombinant human insulin
T2 - A novel pharmacotherapy for feeding intolerance in preterm infants
AU - Mank, Elise
N1 - UvA
PY - 2023/4/13
Y1 - 2023/4/13
N2 - Feeding intolerance is a common condition among preterm infants owing to immaturity of the gastrointestinal tract. Clinical symptoms consist of gastric residuals, vomiting, and/or abdominal distention. Feeding intolerance prolongs dependency on parenteral nutrition, which, in turn, is associated with an increased risk of complications (e.g., late-onset sepsis and parenteral nutrition
AB - Feeding intolerance is a common condition among preterm infants owing to immaturity of the gastrointestinal tract. Clinical symptoms consist of gastric residuals, vomiting, and/or abdominal distention. Feeding intolerance prolongs dependency on parenteral nutrition, which, in turn, is associated with an increased risk of complications (e.g., late-onset sepsis and parenteral nutrition
UR - https://pure.uva.nl/ws/files/120387566/Licentieovereenkomst_medeondertekend_.pdf
UR - https://pure.uva.nl/ws/files/120387568/Stellingen.pdf
UR - https://pure.uva.nl/ws/files/120387570/Changes.pdf
M3 - Phd-Thesis - Research and graduation internal
SN - 9789464830170
ER -
